SEARCH

SEARCH BY CITATION

Keywords:

  • Animal models;
  • pre-eclampsia;
  • pregnancy loss;
  • premature birth;
  • untrauterine growth retardation

Abstract

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

This represents an overview of the use of animal models to study the adverse pregnancy outcomes seen in humans. The purpose is to entice clinicians to utilize some of this information to seek out the literature and have more meaningful and profitable discussions with their academic colleagues and enhance transdisciplinary research in reproductive health.


Introduction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

This represents an overview and not an exhaustive (or systematic literature) review of the use of animal models to study the adverse pregnancy outcomes seen in humans. For several of the outcomes mentioned herein, there exist more in-depth reviews and there likely will be more to follow. Nor is this a review of all the data and mechanisms relating to normal and abnormal pregnancy and parturition. I have decided to include a balance between older reports and observations and reviews by revered scientists, as well as newer observations and reviews by seasoned and perhaps less-seasoned investigators. My hope is that clinicians will be able to utilize some of this information to seek out the literature and have more meaningful and profitable discussions with their academic colleagues. I further hope that they will be enticed to engage in regular interactions that will enhance transdisciplinary research in reproductive health. My ultimate agenda is to eliminate the tendency to dismiss work in animal models out of hand because they do not exactly capture human physiology. In addition, I want to prevent the thinking that little can be learned from observations in humans because of inability to modulate and study-specific mechanisms. I would like to see more support for conversations starting from both sides with ‘This is how I understand how the model behaves and how it might (or not) be reflected in humans. What is your understanding?’ I would also like to see the literature, including titles of manuscripts and keywords increase visibility of the animal models (e.g. including the words ‘animal model’ and species name) involved in the observations conveyed.

Why animal models?

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

The limitations of human studies to establish disease causality and of in vivo animal models to replicate human physiology support the use of animal models in an iterative manner. In this process, phenomena described following observational studies in humans drives hypotheses to be tested in animal experiments. Animal experimentation in turn refines hypotheses that can then be tested in humans. This in turn leads to further questions and more productive animal experimentation. In this iterative approach, studies in humans and animals complement each other and can synergize to move our understanding of disease forward. That being said, my bias is that a good animal is not meant to primarily replicate all of what happens in humans, nor is it meant to be directly transferable. A well-working model generates logical and testable hypotheses that are consistent first foremost with existing data in the animal, and possibly in humans as well. The drive for those who primarily use animal models should be to ‘know thy model’, able to communicate it effectively to others, and to generate productive integrative and iterative study.

An approach to animal models

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

In studies in humans, several properties are taken into consideration to determine the appropriateness of the group of patients accessed for a study. These properties may be related to certain demographics or to prevalence of disease. When considering animal models to study adverse pregnancy outcomes, several issues come to mind.

Resources

With decreasing funding through federal and other sources, cost may play a large role in the choice of mode. Larger animal models are likely more costly and research based on these models is receiving less support.[1] However, certain strains of genetically manipulated mice are also very expensive (http://jaxmice.jax.org). The animal welfare regulatory requirements for non-human primate work are increasingly stringent as is the administrative oversight. Another constraint is the ability to deal with the public relations issues necessary to utilize primate models. Only certain institutions have the capacity, specialized facilities, and highly trained veterinary staff. Depending on the species, there are some zoonotic disease issues that require a very rigorous occupational health program. Another practical issue related to choice of animal models is the presence of experts working with that model. Just as it is often better to watch a relative cooking a family tradition, rather than relying on a recipe, there are likely to be small bits of ‘inside’ or not widely published information about the model that are more easily obtained by direct contact with the investigator utilizing the model.

Placentation

Current thinking would refute the notion that the placenta is just a passive membrane between mother and fetus. Early studies of nutrient uptake suggest that most of the resources delivered to the uterus are utilized by this organ. The placenta is selfish. It is a metabolically, hormonally, and immunologically active entity in a triune necessary for successful pregnancy: mother, fetus, and placenta. Structurally, the purpose of the placenta in mammals is to bring maternal and fetal circulatory systems in close proximity to facilitate exchange of nutrients, oxygen, waste, and other factors.[2] Several good reviews of comparative placentation exist.[3-7] Placentae are usually described by the layers existing between fetal trophoblast, which itself envelops fetal vessels and mesenchymal cells, and maternal blood.[2] The controversy of placentation and the validity of animal models will likely continue because while it is assumed that differences in placentation will lead to different adaptive mechanisms, experimental changing of placentation in certain animals is likely extremely challenging.

The human placenta is said to be hemochorial,[2] in that maternal blood is in direct contact with fetal trophoblast. There are, however, other points of contact between maternal and fetal tissues, for example in the villous structures that anchor the placenta.[8] The human placenta moreover is said to be interstitial, in that implantation occurs completely within the maternal uterine wall[4] thus allowing for multiple points of interaction between maternal and fetal tissues early in gestation. Primates commonly used in research, for example baboons, macaque, chimpanzee, also have hemochorial placentas[3, 6] with more or less invasion upon implantation, and a villous organization, although this is not true for all primates (e.g. lemurs[3]). The vascular structure of human placenta undergoes a revision in early gestation in which trophoblast lines maternal uterine arteries[9] to allow for maximal blood flow.[10] The placenta in rats (see recent review by Soares et al.[11]) mice, and guinea pigs (rodents) is similar to that in humans in that maternal blood is in direct contact with trophoblast. There are subtle(?) structural differences between human and rodent placentae, including the flow of blood due to a labyrinthine as opposed to a villous organization, the depth of trophoblast invasion,[6] and the trophoblast subpopulations.[2] For example, an additional layer of trophoblast, the giant cell layer, in addition to cytotrophoblast and syncytital trophoblast has led some authors to call the rodent placenta ‘hemotrichorial’. Because of only one trophoblast layer, the guinea pig placenta is sometimes referred to as ‘hemomonochorial’. In addition to structural differences, there are subtle differences in the expression of proteins, such as those involved in immune regulation.[12-15] While the definitive placenta is in place for a short time relative to gestation in mice and rats,[2] the longer gestation in guinea pigs makes this less true. Rabbits belong to the group of mammals called lagomorphs. Their placentas are hemochorial with two trophoblast layers, a syncytium layer and a cytotrophoblast layer, which is similar to humans, but organized in a labyrinthine structure.[2, 5, 16] Sheep and pigs belong to the group of mammals called ruminants (order Artiodactyla) and have a different placental structure where both trophoblast and uterine epithelium are intact but interdigitate (epitheliochorial, think fingers of folded hands) allowing for contact close enough for efficient gas exchange.[2] In some areas of the sheep placenta, called placentomes, there is aggressive interdigitation between trophoblast villi on the fetal side (cotyledon) and the uterus on the maternal side (caruncle), and at points the epithelia form a common syncytium allowing for more efficiency of gas and nutrient exchange. Pigs have a similar but more diffuse placental structure than sheep with less aggressive interdigitation.[2, 17]

Uterine Structure, Dynamics

The human/primate uterus is a single muscular organ different structurally from the two-horned uterus of rodents (for mice see Margaret J Cook's book at www.jax.org), pigs,[18] rabbits,[16] or sheep.[19] While the electro-mechanics of the human/primate uterus may be fundamentally different from that seen in other species,[20, 21] the uteri of rodents,[22] rabbits[23] sheep,[24] and pigs[18] respond to oxytocin, suggesting a common expression of the receptor, and most have been used to study the mechanisms underlying uterine contractility in vitro.

Endocrinology of Pregnancy

In addition to hormones such as estrogen (discussed elsewhere), progesterone is a key hormone of pregnancy that appears to be differentially regulated in humans and animals.[25] The particulars of the responsiveness to this hormone and its interaction with estrogen in successful pregnancy remain a topic of intense investigation. In humans, the corpus luteum is the major site of progesterone expression with help from chorionic gonadotropin released by the early conceptus.[26] Blockade of progesterone during this time causes pregnancy loss.[26] Major production of progesterone switches to the placenta by 5–6 weeks’ gestation. Maternal serum levels of progesterone raise post-conceptionally and continue to elevate beyond parturition.[25, 27] However, progesterone has been given with variable success to treat women with recurrent miscarriage[28] and antiprogesterone given late in pregnancy can cause cervical ripening and delivery in some women[29] suggesting a complex biology.

Human fetal membranes can produce[30] and metabolize progesterone,[31] and locally produced progesterone metabolites may be important in uterine quiescence and activation.[32] The human uterus can produce an inhibitory progesterone receptor which increases before parturition.[33] Finally, progesterone receptor regulation at multiple levels in the cytoplasm and the nucleus may regulate functional progesterone activity leading to parturition.[34] Progesterone's regulation during pregnancy in related non-human primates is similar to human pregnancy in several respects including dependence on early production of progesterone by the corpus luteum[35] that early pregnancy can be interrupted by antiprogestins[36] and that there is not systemic withdrawal before parturition.[37]

In rodents, the corpus luteum is the source of progesterone that maintains pregnancy. Luteolysis,[38] removal of the ovaries,[39] or administration of antiprogestational agents[40] leads to uterine activation with increased effective signaling through oxytocin or other receptors and parturition. The difference in serum levels before parturition in mice and rats is said to make these animal a poor model for progesterone regulation in humans. However, further understanding of local progesterone metabolism and responsiveness is likely to reveal mechanisms that are to some extent important in humans and may be a natural stand in for women who do not respond to exogenous progesterone in the prevention of preterm birth. Rats also express an inhibitory receptor that increases in expression before parturition.[41]

In guinea pigs, in which early pregnancy can be disrupted by antiprogestins,[42] maternal serum levels, similar to what is seen in humans, rise from the time of conception to a peak in early gestation followed by a transient decrease in late gestation and increasing levels from that point beyond the time of parturition.[25] Rabbits and sheep in contrast have very low levels of progesterone in the serum as compared to humans, and in these animals, pregnancy brings a slight increase in serum progesterone and a rapid fall before parturition.[25]

Another important endocrine system related to pregnancy is the hypothalamic pituitary adrenal axis,[43] both of the mother and the fetus. Activation of the HPA axis by stress or other factors initiates a cascade involving release of corticotropin-releasing hormone (CRH) from the hypothalamus, secretion of corticotropin (ACTH) from the anterior pituitary, and action of ACTH on the adrenal to release cortisol and other glucocorticoids which can then exert feedback suppression on their release. This system not only interacts with the immune system, but is also thought to be part of the mechanism underlying poor pregnancy outcomes related to emotional or physiologic stress.[44, 45] CRH, a principle mediator of the HPA axis, is produced by the placenta and fetal membranes[45] and may be a mediator of local estrogen production. In pregnant women, the possibility for multiple sources of increased systemic CRH presents an ongoing challenge in understanding the interaction between maternal stress, fetal stress, and normal HPA development in the generation of parturition or preterm birth.[46] Animal models are likely critical in the examination of this issue in that they can be used to isolate and understand the potential importance of maternal versus fetal HPA and other factors[47, 48] in this process.

In related non-human primates, the placenta also expresses CRH, and development of the fetal adrenal and activation of the fetal HPA axis generate important support signals for normal labor.[48] Compared with humans, the biochemistry of adrenal steroid production and the development of the fetal adrenal gland in various non-human primates show subtle differences that may need to be considered in choosing a primate model to examine the role of the HPA axis in normal development or prematurity.[49]

In rats and mice, the HPA axis expresses important differences from that found in humans. For example, the major product of HPA axis activation in humans is cortisol, while that in most rodents is corticosterone.[50] Moreover, the development of the fetal adrenal gland in rats and mice is markedly different with major relative deficiencies in important enzymes and preference for different substrates. In these species, the response to stress may lead to fundamentally different means of pregnancy failure, including a decreased level of circulating progesterone.[51] While rodent models may not be ideal for the examination of the role of HPA axis in normal pregnancy, evolving rodent models may be of interest in understanding the interaction of the HPA axis and stress in parental behavior.[52]

Sheep have been used as a model of maternal[53] and fetal HPA axis function during pregnancy. In this animal model, it is the development and activation of the fetal HPA that is the primary driver of parturition,[54] and stresses such as hypoxia activate the HPA axis in sheep and lead to preterm labor.[55]

Immune System

The maternal–fetal interface in humans includes close contact between maternal and fetal cells not only within the placenta and uterus[8] but also within the maternal and fetal circulations, as cellular traffic has been shown in either direction.[56, 57] The expression of proteins unique to the mother on fetal cells has raised a decades-long debate over the critical pathways and mechanisms needed to assure both immune tolerance and protection of the fetus from infection.[58] Humans can mount an immune response against fetal antigens during pregnancy,[59] and it is clear that there is an intricate interaction between maternal immune cells and trophoblast.[60, 61] This interaction may be of benefit to the evolving conceptus[62] or may be involved in early pregnancy loss or other adverse pregnancy outcomes.[63] Activation of local innate immunity within the myometrium is thought to play a role in parturition[64] and in premature uterine contractions.[65] In humans, certain pathogens are more deleterious during pregnancy as compared to the non-pregnant state,[66] while others are not,[67] and the role of the placenta as a safe harbor for evolving pathogens has been described.[68] Some infection syndromes that occur in humans occur only under contrived conditions in animals.[69] Moreover, some organisms, such as CMV, are different in different hosts.[70] Both the peculiarities of the immune response and the infectious agent must be taken into consideration when using an animal model to understand the function of the immune response during pregnancy.

The maternal–fetal interface in primates expresses similar oligomorphic major histocompatibility (MHC) molecules[71] and other immune modulating factors[48] as are found in humans. Similar populations of immune cells have also been observed in the primate uterus and placenta during pregnancy.[72-74] Moreover, shared susceptibility to certain infections exists.[75] In addition, the high degree of sequence similarity between key human and non-human primate protein sequences has supported the use of anti-human antibodies in ELISA and other immune assays to examine the immune response in non-human primates. These factors have made primate models useful for the study of infection, immunity, and adverse pregnancy outcome.

Mice have also been used extensively to model both maternal innate and adaptive immunity. There has been extensive study on the trafficking of cells across the maternal–fetal interface[76-78] and on the intricate interaction between trophoblast and innate immune cells in gestation.[79, 80] While there are some differences in the phenotype of natural killer (NK) cells at the maternal–fetal interface,[81] and differences in the diversity of the MHC molecules expressed on trophoblast subpopulations in humans and mice,[82] both systems have been used to delineate specific mechanisms and paint a picture of NK cells as ‘educable’,[83, 84] supportive of placental structure and development,[82] but potentially participating in disruption of pregnancy[85] (and see below).

The mouse has also been used to examine maternal T cell regulation during pregnancy. As in the human, the pregnant mouse can generate a fetus-specific immune response,[77] including effector and regulatory T cells.[86, 87] An advantage to the mouse is the ability to vary the genetic difference between mother and fetus. For example, some strains of mice respond to the male antigen, H-Y, and thus, maternal immunity can be studied in a situation where mother and fetus are genetically identical, except for the expression of proteins relevant to maleness. The so-called anti-H-Y response is generated in mouse pregnancy[77] and has been shown to shown modulate both CD4[88] and CD8[89] maternal T cells. Several genetically modified antigen systems have been used to examine maternal anti-fetal immunity in pregnant mice.[90] Although human but not mouse T cells can present antigen via MHC II, the mouse has also been used to examine fetal antigen-presenting cells during pregnancy.[91, 92] Integrated studies in mice and humans will likely increase our knowledge of the function of the immune system during pregnancy and reveal the presence and importance of specific pathways.

Guinea pigs and humans have similar immune systems making them a useful tool in the study of relevant human infectious diseases.[93] Guinea pigs are extensively used in models of anaphylaxis and allergy.[94] Many tools are now available to examine the immune system in these animals.[95]

The rabbit has also been used for a variety of immunology and infectious disease research. The whole genome of the rabbit has been sequenced and utilized to determine possible genomic differences in loci responsible for immunity.[96]

As in humans and mice, systemic immunity during pregnancy has been examined in sheep. Some studies have found no alteration during pregnancy,[97] while other studies have found the sheep produces pregnancy-specific agents that can suppress immune responses.[98] In human pregnancy, there is a systemic turnover of a subtype of T cells, bearing gamma- and delta-chain T cell receptor in the peripheral blood.[99] These gamma–delta T cells are also present in the deciduas[100] and may play a role in fetal protection.[101] A highly diverse population of gamma–delta T cells is present in sheep uterus during pregnancy, providing large numbers of cells for study.[102, 103] Pigs have also been studied to understand immunity at the maternal–fetal interface and, for example, underline the importance of uterine NK cells.[104]

Length of Gestation and Fetal Development

In human and other primate gestation, implantation is ~ 7–8 days after ovulation followed by a 10-week-long pre-embryonic and embryonic period.[28] This is followed by a prolonged fetal period resulting in a highly developed fetus in relatively low numbers. During this time, multiple insults inside and outside the uterus can disrupt both pregnancy and fetal well-being. For ease of experimentation, a shorter length of gestation, such as found in most rodents (i.e. ~ 19–22 days), may be desired. However, the rodent fetus is born less developed than the human.[105] Currently, tissue-specific inducible promoters, Cre recombinase, and related technology allow for the generation of genetically based time- and tissue-specific modulation of gene expression during mouse pregnancy. These changes can be examined in the developing fetus and the newborn. However, this technology may be difficult to obtain, and mice with the desired modifications may not exist. Moreover, the short gestation and small fetal size constrain the ability to make specific surgical or physiologic interventions and relate these to fetal development. While rats are relatively larger, and more amenable to these interventions, the technology to generate targeted gene expression or deletion in rats is less-developed or utilized.[106]

The guinea pig is a rodent used in many studies of maternal environment and fetal development, as it has a longer gestation of 68 days,[2] and its offspring are born highly precocious[105] with a mature central nervous system at birth.[105] Another rodent with a longer gestation is the ‘spiny mouse’ of the genus Acomys (not Mus as in mice). This small rodent has a relatively long gestation (38–42 days) and gives birth to a small litter (2–3 pups) that are born highly developed.[107] These exotic animals, however, are difficult to manage due to their delicate skin.[108] There is a long and distinguished history using rabbits to understand early development.[16] In rabbits, ovulation is induced by mating, resulting in an exactly defined pregnancy and embryonic age assessment. Larger animals, such as sheep, have long and lower-order gestations (singleton/twin) and produce highly developed offspring and thus have been used for studies of pregnancy insult on fetal development.[109]

Pre-eclampsia

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

Pre-eclampsia is a pregnancy-related syndrome that affects multiple systems and clinically presents as hypertension, proteinuria, edema, and in its more sever forms evidence of fetal compromise, neurologic abnormality, liver and hematologic dysfunction.[110] The complexity of the syndrome defies the development of a panel of genetic screens or biomarkers.[111] While the basic cause of the disease is as yet unknown, multiple hypotheses exist. These include failure of placentation[112] and thus reduced utero-placental perfusion, intolerance to volume expansion generated by pregnancy,[113] infection,[114] and inflammation.[115] It is hotly debated as to whether failed placentation is caused or a by-product of broken maternal immune tolerance.[116, 117] Many agree that a common final pathway to the manifestation of the disease is endothelial cell damage occurring in a variety of vascular beds.[118]

While the disease is thought of as being unique in human, many recognize the potential positive role of the integration of research in human and animal models in understanding the underlying mechanisms.[119, 120] The hallmarks of pre-eclampsia most sought after in animal models are hypertension, renal dysfunction (proteinuria), and further, conditions such as poor trophoblast invasion and endothelial damage. Current models address some of these issues.

There have been rare reports of spontaneous pre-eclampsia in related non-human primates.[121] These species have also been used to develop models of pregnancy-related hypertension and proteinuria based on injection during mid-gestation of inflammatory mediators, such as tumor necrosis factor[122] or antibodies to interleukin 10.[123]

There are strains of mice that spontaneously develop hypertension, proteinuria, smaller litters, and fetal demise, and these have been used to model pre-eclampsia.[124, 125] There are also models of spontaneous pregnancy-associated hypertension with fetal compromise in rats.[126] There also exist genetically manipulated mouse and rat models. In one interesting genetic model of hypertension in pregnancy, female mice transgenic for human angiotensinogen are mated to males transgenic for human rennin.[127] The resulting pregnancy is marked by distortion of placental anatomy, elevation of circulation vascular endothelial growth factor (VEGF) receptor in mid-gestation (12–13 of 19–20 days), hypertension, fetal intrauterine growth retardation, and systemic maternal disorders including proteinuria and convulsion. In the rat version of this model,[128] the hypertensive disease experienced by the pregnant rat is thought related to secretion of rennin from the placenta into the maternal circulation.[129] Interestingly, the extent of trophoblast invasion into the spiral arteries in these pregnancies was increased compared with non-pregnant animals, and the breeding, when performed in reverse (dams transgenic for rennin males for angiotensinogen), was associated with lower blood pressure. Overall studies in humans, in vitro, and in animal models have yielded interesting hypotheses surrounding the placenta as an independent factor in the development of pre-eclampsia. Animal models, in conjunction with genetic studies in humans,[113] will likely elucidate an important underlying mechanism(s) for the disease.

To model the presumed decrease in placental perfusion that occurs as part of the mechanism proposed to incite pre-eclampsia,[130] workers have ligated various levels of the uterine artery. The RUPP or reduced uterine perfusion pressure model (reviewed in[131]) is performed in rats and several other animals. In rats, the model is performed at around 14 days of gestation by placing a clip above the aortic bifurcation and on both sides of the uterine arcade to prevent utero-ovarian collateral flow. This results in a 40% or more reduction in flow to the developing fetal-placental units, and the resulting disease includes hypertension, renal damage (proteinuria), increased vascular reactivity, and small pups. In rats, an alternative of this model is based on increased salt intake and administration of desoxycorticosterone acetate,[132] which generates hypertension, convulsions, proteinuria, and renal lesions.[133]

Other rodent models of reduced vascular function have utilized injection of inhibitors of nitric oxide [i.e. L-NAME (N-omega-nitro-l-arginine methyl ester[134])], or overexpression of soluble VEGF receptor (sVEGFRI, sFLT1) or members of the transforming growth factor β receptor complex (i.e. endoglin). Adenovirus-driven overexpression of sFLT1 in pregnant rats leads to hypertension and proteinuria in a dose-dependent manner,[135] and this is enhanced by overexpression of soluble endoglin.[136]

Other animals have also been used to develop models of pre-eclampsia. In guinea pigs, there have been reports of a naturally occurring pre-eclampsia-like syndrome.[137] In addition, it has been observed that banding of the uterine arteries as well as transaction of the ovarian arteries before pregnancy results in later pregnancy hypertension, proteinuria, and elevated creatinine.[138] Moreover, early observations of constriction of the aorta in pregnant rabbits revealed that such manipulation generated hypertension, proteinuria, weight gain, and reduced weight of the fetus.[139] Finally, sheep experience what is called toxemia of pregnancy that appears to be a very different metabolic disorder as compared to pre-eclampsia,[140] but does include proteinuria and inflammation.[141]

Intrauterine growth restriction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

In humans, intrauterine growth restriction (IUGR) can be an independent outcome of a fetal abnormality or related to placental insufficiency due to a number of maternal/environmental factors including poor nutrition, smoking, and chronic infection, or in the context of pre-eclampsia.[142] Poor intrauterine growth has been extensively studied in animals,[143] and thus, the time is ripe for more extensive integration of the information in humans and animals.

In related primates, IUGR has been induced using various levels of maternal nutrient restriction[144] and surgical manipulation of placental blood supply[145] among other interventions. In animals with litters, there is evidence that the fetuses placed at a distance from the main uterine artery are smaller.[146] In pigs, a proportion of piglets in a litter is naturally small.[146, 147]

In mice, genetic models of deficiency in key molecules such as eNOS have been generated and pups of these pregnancies show IUGR,[148] while their mothers do not show a characteristic mid-gestation drop in systemic blood pressure.[149] In mice and rats, bilateral uterine artery ligation late in gestation leads to fetal intrauterine growth retardation, neurologic deficiency, and metabolic derangement.[150] Uterine artery ligation at mid-gestation (~day 30 of 70) in guinea pigs also produces growth restriction.[151]

Ligation of utero-placental vessels in rabbits on day 25 of a 31-day gestation produces small pups that show deficiencies in neurobehavioral development.[152] Administration of L-NAME on days 24–28 of gestation is also used to model IUGR in a rabbits, and this model results in growth-retarded fetuses and decreased flow, as determined by 3D power Doppler Angiography, in each utero-placental unit.[153]

In sheep, there are several models of fetal growth restriction.[109] These include maternal calorie restriction[154] emobilization of the umbilico-placental arteries[155] and disruption of the uterine epithelium in close contact with trophoblast in the placenta.[156] Maternal hyperthermia on days 35–40 of gestation (total gestation ~147 days) has been shown to produce asymmetrical growth restriction and decreased placental mass,[157-159] and abnormal umbilical arterial and aortic Doppler velocimetry,[160] while placement of the mother in hypoxic conditions also limits fetal growth.[161] Some breeds of sheep are more amenable to these manipulations than others,[109] suggesting that with advanced technology and genome sequencing, these animals may be used to examine gene–gene and gene–environment interaction in the development of this disease.

Recurrent miscarriage

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

Human pregnancy is less efficient than many other species, as nearly 50% of conceptions fail.[28] In humans, recurrent miscarriage is a complex syndrome that likely incorporates several types of defects in genetics, implantation, placentation, metabolism, and hormonal support of the conceptus[28, 162] or stress.[163] Thoroughbred horses[164] and commercial pork breeds[165] also have a high rate of spontaneous abortion. One idea that drives the field is that disregulation of maternal innate or adaptive immunity initiates or contributes significantly to the disease.[166, 167] Immune modulation as a treatment in human disease has met with variable success, and this is still a matter of controversy.[168] Whether an initial metabolic, structural, or related defect leads to immune activation and a subsequent deleterious response or an initial loss of immune regulation leads directly to tissue disregulation and destruction is still a matter of debate in some circles. Thus, the issue of immune-mediated recurrent pregnancy loss is one that is likely amenable to iterative studies in animal models and humans.

In primates, parental sharing of MHC has been correlated with decreased pregnancy success.[169] Moreover, administration of antiprogestational agents can produce early pregnancy loss, as in humans.[170] Primates have also been used to develop models of pregnancy loss related to infections.[171]

A well-known mouse model of pregnancy loss involves the breeding of a CBA strain female mouse with a DBA strain male mouse. Depending on the source and housing (level of pathogens present) of the mice, pregnancies can be affected by high levels of fetal-placental degeneration (referred to as ‘resorption’)[172] and infiltration with NK and other immune cells.[173] In this model, resorption of the fetuses occurs at approximately 9–12 days of gestation.[174] Contributors to increased fetal loss in this model include stress,[175] inflammation[176, 177] abnormal cytokine milieu within the placenta/decidua,[178, 179] disrupted regulatory immune modulation,[180, 181] and abnormal placental vascular development.[182, 183] Several methods of immune modulation[184-187] have been shown to decrease fetal loss in this model, but few if any have been successfully translated to clinical care.[28] More recent models of pregnancy loss in mice involves chemically targeting[86] depletion[87] or genetic deficiency of a subpopulation[188] of regulatory T cells in normal C57Bl/6 females mated to same strain or allogeneic males. An alternative immune-based models of pregnancy loss involved NK T cell activation in certain strains of mice[189] and systemic immune activation leading to ovarian insufficiency.[38]

Study of the high rate of pregnancy loss in commercial pork breeds has further suggested the role of immune cells in supporting successful pregnancy.[190] Moreover, Guinea pigs (for example[191]) and Sheep[192] have been used in models of early pregnancy loss in response to infection. Finally, autoimmune-related loss, as in the antiphospholipid syndrome, has been modeled in rabbits.[193]

Preterm birth/prematurity

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

The study of premature birth presents at least three major issues that are amenable to studies in animal models.[194] The first is the discovery of mechanisms leading to premature labor. A second pertains to delineating consequences of being born premature. Third, animal models have been employed to devise ways to better manage the premature neonate. While the factors contributing to prematurity in humans are far from understood, emerging data suggest that preterm births fall into definable categories.[195] These categories include preterm births in women who have a history of preterm birth,[196] women with multiple gestations,[197] women who are undergoing an infectious or inflammatory process,[198-200] women who undergo social and emotional stress,[201] and women who have medically indicated or physician-driven premature births.[202] While in general, animals are not said to experience preterm birth, there is variability in gestation within species. Recent data, for example, suggest that there is significant variability in mouse gestation related to strain[203] or cytokine expression.[204]

Endocrine Disruption

Progesterone has been used in various formats for the prevention of preterm birth.[205, 206] Clearly, there are patients who respond to progesterone and those who do not. Only a proportion of women respond to vaginal progesterone, particularly if the cervix in shortened. Even among women with a tendency toward preterm birth as evidenced by a previous premature delivery, there are those who respond to regular administration of a progestational agent, while others do not. Finally, with the reinstatement of progesterone and related agents in the past decade, there remains a significant incidence of preterm birth.[207] Use of animal models in conjunction with a more careful study of responders versus non-responders[208] in human trials of progesterone and related agents will enhance our understanding and management of pregnancy.

Decreased relative progesterone activity can be modeled in mice via oophorectomy or administration of agents such as RU486 in primates (see above). Preterm birth can also be generated in rabbits using RU486.[209] Novel models of endocrine disruption in mice[210] and likely other animals are being developed. In several animal models, a signal from the fetus, the placenta, or the endometrium leads directly or indirectly through a systemic response circuit to decreased relative progesterone activity and increased estrogen activity.[211, 212] This in turn leads to increased prostaglandin (increased production, decreased hydrolysis), uterine contractions, cervical ripening, and subsequent rupture of membranes and expulsion of the fetus. For example, the stress response, thought to be mediated by cortisol, is modeled in sheep by systemic administration of glucocorticoid[213] or in the fetus.[214] The complexity of these models is likely to increase and bring forth possible means to modify the process of disrupted endocrine function in premature birth.[34]

Immune/inflammatory In very well-studied models in mice (for examples[215-217]), rabbits,[218-220] and primates,[221-223] exposure of the uterus to an inflammatory signal or infectious process leads to an increased local presence of inflammatory cells[217, 224] and feeds into the mechanisms resulting in increased uterine contractions or cervical ripening and subsequent preterm birth. An interesting alternative inflammatory model involves injection of a major lung surfactant protein which is thought to activate uterine macrophages and lead to preterm birth.[212] Guinea pig uterus is particularly sensitive to mast cell–secreted mediators, making this a potentially important model for examining the role of allergy an preterm birth.[225, 226]

A salient example of the iterative nature of successful research in animals and humans is the work surrounding Toll-like receptors and preterm birth. In the early 1960s, it was recognized that urinary tract infections in women were associated with preterm birth.[227, 228] The 1970s brought forth reports that lipopolysaccharide, a component of the outer membrane of gram-negative bacteria, interrupts early and late pregnancy in mice[229] and rats.[230] In 1985, the Toll gene in Drosophila was cloned.[231] The early 1990s brought studies suggesting that LPS-induced preterm delivery induced changes in local and systemic cytokines including tumor necrosis factor-alpha and interleukins 1,6, and 8.[232, 233] In the late 90s, the drosophila Toll gene was linked to antifungal immunity and the delineation of the Toll-like receptor (TLR) family of proteins began.[234-236] At this time, it was recognized that a certain strain of mice was hypo-responsive to LPS.[237] That these mice possessed mutations in the Tlr4 locus generated much excitement that Tlr4 was the innate receptor for LPS and the link between infection and LPS-mediated inflammation. The early 2000s brought studies trying to link polymorphisms in Tlr4 to LPS responsiveness, preterm labor, and preterm premature rupture of membranes in humans.[238] In the mid-late 2000s, investigators using mouse models determined that preterm delivery induced by bacteria expressing LPS is dependent on TLR4 signaling.[215] They delineated several relevant pathway constituents, including Myeloid Differentiation primary-response gene 88 (MyD88),[239] nuclear factor kappa B(NFκB)[240] cytokines, such as tumor necrosis factor and others[241] and prostaglandins.[242] At about this time began studies of expression and regulation of these molecules and their pathways in human placenta, uterus, and decidua[243, 244] and the correlation between Tlr4 expression and other adverse pregnancy outcomes in humans.[115, 245] Recently, a TLR4 antagonist was tested in a rhesus model for decreasing LPS-induced inflammation and uterine contractions.[222] Moreover, the role of other TLR molecules in preterm birth[246-248] has generated experiments linking bacterial and viral co-infection with preterm birth,[249] suggesting synergy in signaling from two TLRs. Finally, data are developing that link circulating fetal DNA and yet other TLRs with this process.[250]

Important complications of prematurity in humans that are investigated in animal models include white-mater damage and cerebral hemorrhage which is thought to be the basis for cerebral palsy and learning disability.[251] Studies of preterm birth in humans have supported the idea that not only infection but also inflammation is a significant underlying cause of preterm birth.[252] In addition, these data have contributed to the idea that the fetus generates a significant inflammatory response under these conditions[253] and that this response may subject the fetal brain to processes leading to cerebral palsy.[254] Several animal models have been used to examine fetal neurologic insult in the context of maternal systemic infection or inflammation and the resulting preterm labor. These studies have included systemic injection of LPS in pregnant sheep[255] and intrauterine injection in rabbits[256] and in mice.[257-259] The mouse model of preterm birth initiated with injection of LPS revealed the important role of the cytokine interleukin 10.[260, 261] In addition, human studies have suggested the potential role of this cytokine in modifying preterm birth-related brain injury.[262] The study of inflammation-related preterm birth and brain injury offers another opportunity for productive iterative study in humans and animals.

Adverse fetal programming

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

‘Programming’ is said to occur during ‘a critical period when the system is plastic and sensitive to the environment followed by loss of plasticity and a fixed functional capacity’.[263] ‘Fetal programming’ in humans is said to occur as a result of adaptation to undernutrition in an adverse intrauterine environment contributes significantly to obesity, metabolic syndrome, and cardiovascular disease.[264] Increasingly, animal models are being used to delineate these mechanisms, and several models utilizing rats, mice, rabbits sheep, and non-human primates have been utilized (see Fischer et al.,[16] Seki et al.,[265] and Vuguin[158] for reviews)]. Some of these models proceed through well-recognized defects in fetal development, such as IUGR. This issue is one that is ripe for an iterative process involving studies in animals and humans. An area that would be particularly amenable to animal experimentation would be the examination of multigenerational effects of exposure during pregnancy.[266]

Is the Future Now? Bioinformatics and the Iterative use of Animal Models

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

Although the relevant tissue in humans is sometime hard to access, genetic variability found from sampling peripheral blood can be informative in conjunction with specific gene manipulation in rodents. For example, technology exists to manipulate embryos by using viral constructs to target genes to trophoblast.[11, 267] It is therefore not difficult to imagine an experimental paradigm whereby candidate genes from human genetic studies would be considered for overexpression or ‘knock down’ in trophoblast using this technology. Pregnancies using these manipulated embryos could then be observed or further challenged and observed for preterm birth. In this way, and perhaps many others, bioinformatics, systems biology, and the use of animal models could be woven into and increasingly efficient iterative method to understand the complex biology of abnormal pregnancy.

The overwhelming increase in genomic, transcriptomic, proteomic, metabolomic, and now microbiomic data in human disease requires continued development of methodologies to probe and understand existing data. Once understood, however, specific genes/proteins reveal themselves as important and these can then be analyzed in animal models.[268] Similarly, ‘omic’ data from animal models can theoretically be used to query existing repositories from human studies.[269]

Finally, the large amount of data in both humans and animal will further advance our ability to mathematically model pregnancy[270] and perform in silico experiments and use machine learning.[271] The time may come when the iterative method I propose between human studies and animal models may require this third facet in the quest to understand reproduction.

Post-note

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

This shallow overview was meant to increase curiosity and enhance discussion between clinicians and researchers who utilize animal models in the study of adverse reproductive outcomes. The solution to these problems will come from an integrative and iterative method that starts from clear identification of studies in animals in the literature, an enhanced understanding of the available models, and the increased willingness to see value in what at first may seem obscure.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References

I apologize to those colleagues whose excellent work was, due to space considerations, not cited herein. I am grateful for present and past support from the Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont College of Medicine, NIH RO1 HD043185, and The March of Dimes Prematurity Research Initiative. I am also grateful for the intellectual support of my colleagues in The Preterm Birth International Collaborative (PREBIC).

References

  1. Top of page
  2. Abstract
  3. Introduction
  4. Why animal models?
  5. An approach to animal models
  6. Pre-eclampsia
  7. Intrauterine growth restriction
  8. Recurrent miscarriage
  9. Preterm birth/prematurity
  10. Adverse fetal programming
  11. Is the Future Now? Bioinformatics and the Iterative use of Animal Models
  12. Post-note
  13. Acknowledgements
  14. References
  • 1
    Roberts RM, Smith GW, Bazer FW, Cibelli J, Seidel GE, Bauman DE, Reynolds LP, Ireland JJ: Farm animal research in crisis. Science 2009; 324:468469.
  • 2
    Enders AC, Blankenship TN: Comparative placental structure. Adv Drug Deliv Rev 1999; 38:315.
  • 3
    Wildman DE, Chen C, Erez O, Grossman LI, Goodman M, Romero R: Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc Natl Acad Sci U S A 2006; 103:32033208.
  • 4
    James JL, Carter AM, Chamley LW: Human placentation from nidation to 5 weeks of gestation. Part II: Tools to model the crucial first days. Placenta 2012; 33:335342.
  • 5
    Enders AC, Carter AM: Review: the evolving placenta: different developmental paths to a hemochorial relationship. Placenta 2012;33(Suppl.):S92S98.
  • 6
    Carter AM: Animal models of human placentation – a review. Placenta 2007;28(Suppl.):S41S47.
  • 7
    Carter AM, Pijnenborg R: Evolution of invasive placentation with special reference to non-human primates. Best Pract Res Clin Obstet Gynaecol 2011; 25:249257.
  • 8
    Benirschke K: Remarkable placenta. Clin Anat 1998; 11:194205.
  • 9
    Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, Tarpey J, Damsky CH: Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol 1989; 109:891902.
  • 10
    Pijnenborg R, Vercruysse L, Brosens I: Deep placentation. Best Pract Res Clin Obstet Gynaecol 2011; 25:273285.
  • 11
    Soares MJ, Chakraborty D, Karim Rumi MA, Konno T, Renaud SJ: Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface. Placenta 2012;33:233243.
  • 12
    Redline RW, Lu CY: Localization of fetal major histocompatibility complex antigens and maternal leukocytes in murine placenta. Lab Invest 1989; 61:2736.
  • 13
    King A, Boocock C, Sharkey MA, Gardner L, Beretta A, Siccardi AG, Loke YW: Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 1996; 156:20682076.
  • 14
    Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R: A Class I antigen HLA-G, expressed in human trophoblasts. Science 1990; 248:220223.
  • 15
    Kruse A, Hallmann R, Butcher EC: Specialized patterns of vascular differentiation antigens in the pregnant mouse uterus and the placenta. Biol Reproduction 2000; 61:13931401.
  • 16
    Fischer B, Chavatte-Palmer P, Viebahn C, Navarrete Santos A, Duranthon V: Rabbit as a reproductive model for human health. Reproduction 2012; 144:110.
  • 17
    Amoroso EC: The evolution of viviparity. Proc R Soc Med 1968; 61:11881200.
  • 18
    Dittrich R, Mueller A, Oppelt PG, Hoffmann I, Beckmann MW, Maltaris T: Differences in muscarinic-receptor agonist–, oxytocin-, and prostaglandin-induced uterine contractions. Fertil Steril 2009; 92:16941700.
  • 19
    Hadek R: Histochemical studies on the uterus of the sheep. Am J Vet Res 1958; 19:882886.
  • 20
    Young RC: Myocytes, myometrium, and uterine contractions. Ann N Y Acad Sci 2007; 1101:7284.
  • 21
    Young RC, Goloman G: Mechanotransduction in rat myometrium: coordination of contractions of electrically and chemically isolated tissues. Reprod Sci 2011; 18:6469.
  • 22
    Beretsos P, Loutradis D, Koussoulakos S, Margaritis LH, Kiapekou E, Mastorakos G, Papaspirou I, Makris N, Makrigiannakis A, Antsaklis A: Oxytocin receptor is differentially expressed in mouse endometrium and embryo during blastocyst implantation. Ann N Y Acad Sci 2006; 1092:466479.
  • 23
    Cross BA: On the mechanism of labour in the rabbit. J Endocrinol 1958; 16:261276.
  • 24
    Sheldrick EL, Flint APF: Endocrine control of uterine oxytocin receptors in the ewe. J Endocrinol 1985; 106:249258.
  • 25
    Mitchell BF, Taggart MJ: Are animal models relevant to key aspects of human parturition?. Am J Physiol – Reg Integ Comparat Physiol 2009; 297:R525R545.
  • 26
    Norwitz ER, Schust DJ, Fisher SJ: Implantation and the survival of early pregnancy. N Engl J Med 2001; 345:14001408.
  • 27
    Tulchinsky D, Hobel CJ, Yeager E, Marshall JR: Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol 1972; 112:10951100.
  • 28
    Porter TF, Scott JR: Evidence-based care of recurrent miscarriage. Best Pract Res Clin Obstet Gynaecol 2005; 19:85101.
  • 29
    Neilson JP: Mifepristone for induction of labour. Cochrane Database Syst Rev 2000; 4:CD002865.
  • 30
    Maslar IA, Hess DL, Buckmaster JG, Lazur JJ, Stanczyk FZ, Novy MJ: Steroid production by early pregnancy human placental villi in culture. Placenta 1990; 11:277288.
  • 31
    Milewich L, Gant NF, Schwarz BE, Chen GT, Macdonald PC: Initiation of human parturition. IX. Progesterone metabolism by placentas of early and late human gestation. Obstet Gynecol 1978; 51:278280.
  • 32
    Sheehan PM: A possible role for progesterone metabolites in human parturition. Aust N Z J Obstet Gynaecol 2006; 46:159163.
  • 33
    Mesiano S, Chan E-C, Fitter JT, Kwek K, Yeo G, Smith R: Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor a expression in the myometrium. J Clin Endocrinol Metab 2002; 87:29242930.
  • 34
    Williams KC, Renthal NE, Condon JC, Gerard RD, Mendelson CR: MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor. Proc Natl Acad Sci U S A 2012; 109:75297534.
  • 35
    Duffy DM, Stouffer RL, Stewart DR: Dissociation of relaxin and progesterone secretion from the primate corpus luteum by acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor during the menstrual cycle. Biol Reprod 1995; 53:447453.
  • 36
    Micks E, Shekell T, Stanley J, Zelinski M, Martin L, Riefenberg S, Adevai T, Jensen J: Medical termination of pregnancy in cynomolgus macaques. J Med Primatol 2012; 41:394402.
  • 37
    Walsh SW, Stanczyk FZ, Novy MJ: Daily hormonal changes in the maternal, fetal, and amniotic fluid compartments before parturition in a primate species. J Clin Endocrinol Metab 1984; 58:629639.
  • 38
    Erlebacher A, Zhang D, Parlow AF, Glimcher LH: Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system. J Clin Investig 2004; 114:3948.
  • 39
    Terakawa J, Watanabe T, Obara R, Sugiyama M, Inoue N, Ohmori Y, Hosaka YZ, Hondo E: The complete control of murine pregnancy from embryo implantation to parturition. Reproduction 2012; 143:411415.
  • 40
    Dao B, Vanage G, Li XJ, Bardin CW, Koide SS: Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the rat. Contraception 1997; 55:3540.
  • 41
    Fang X, Wong S, Mitchell BF: Messenger RNA for progesterone receptor isoforms in the late-gestation rat uterus. Am J Physiol – Endocrinol Metab 2002; 283:E1167E1172.
  • 42
    Elger W, Fahnrich M, Beier S, Qing SS, Chwalisz K: Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs. Am J Obstet Gynecol 1987; 157:10651074.
  • 43
    Mastorakos G, Ilias I: Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 2003; 997:136149.
  • 44
    Entringer S, Buss C, Andersen J, Chicz-DeMet A, Wadhwa PD: Ecological momentary assessment of maternal cortisol profiles over a multiple-day period predicts the length of human gestation. Psychosom Med 2011; 73:469474.
  • 45
    Torricelli M, Novembri R, Bloise E, De Bonis M, Challis JR, Petraglia F: Changes in placental CRH, urocortins, and CRH-receptor mRNA expression associated with preterm delivery and chorioamnionitis. J Clin Endocrinol Metab 2011; 96:534540.
  • 46
    Smith R, Smith JI, Shen X, Engel PJ, Bowman ME, McGrath SA, Bisits AM, McElduff P, Giles WB, Smith DW: Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J Clin Endocrinol Metab 2009; 94:20662074.
  • 47
    Pearce BD, Grove J, Bonney EA, Bliwise N, Dudley DJ, Schendel DE, Thorsen P: Interrelationship of cytokines, hypothalamic-pituitary-adrenal axis hormones, and psychosocial variables in the prediction of preterm birth. Gynecol Obstet Invest 2010; 70:4046.
  • 48
    Gravett MG, Novy MJ: Endocrine-immune interactions in pregnant non-human primates with intrauterine infection. Infect Dis Obst Gynecol 1997; 5:142153.
  • 49
    Conley AJ, Pattison JC, Bird IM: Variations in adrenal androgen production among (nonhuman) primates [Review] [171 refs]. Sem Reprod Med 2004; 22:311326.
  • 50
    Ogunsua AO, de Nicola AF, Traikov H, Birmingham MK, Levine S: Adrenal steroid biosynthesis by different species of mouselike rodents. Gen Comp Endocrinol 1971; 16:192199.
  • 51
    Parker VJ, Menzies JR, Douglas AJ: Differential changes in the hypothalamic-pituitary-adrenal axis and prolactin responses to stress in early pregnant mice. J Neuroendocrinol 2011; 23:10661078.
  • 52
    Harris BN, Saltzman W, de Jong TR, Milnes MR: Hypothalamic-pituitary-adrenal (HPA) axis function in the California mouse (Peromyscus californicus): Changes in baseline activity, reactivity, and fecal excretion of glucocorticoids across the diurnal cycle. Gen Comp Endocrinol 2012; 179:436450.
  • 53
    Keller-Wood M, Cudd TA, Norman W, Caldwell SM, Wood CE: Sheep model for study of maternal adrenal gland function during pregnancy. Lab Anim Sci 1998; 48:507512.
  • 54
    Bernal AL: Mechanisms of labour—biochemical aspects. BJOG: An Int J Obstet Gynaecol 2003; 110:3945.
  • 55
    Myers DA, Ducsay CA: Adrenocortical and adipose responses to high-altitude-induced, long-term hypoxia in the ovine fetus. J Pregnancy 2012; 2012:681306.
  • 56
    Bianchi DW, Zickwolf GK, Yih MC, Flint A, Geifman OH, Erikson MS, Williams JM: Erythroid specific antibodies enhance detection of fetal nucleated erythrocytes in maternal blood. Prenat Diagn 1993; 13:293300.
  • 57
    Adams KM, Nelson JL: Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004; 291:11271131.
  • 58
    Bonney EA, Matzinger P: Much IDO about pregnancy. Nat Med 1998; 4:11281129.
  • 59
    Lissauer D, Piper K, Goodyear O, Kilby MD, Moss PA: Fetal-specific CD8+ cytotoxic T cell responses develop during normal human pregnancy and exhibit broad functional capacity. J Immunol 2012; 189:10721080.
  • 60
    Lash GE, Naruse K, Robson A, Innes BA, Searle RF, Robson SC, Bulmer JN: Interaction between uterine natural killer cells and extravillous trophoblast cells: effect on cytokine and angiogenic growth factor production. Hum Reprod 2011; 26:22892295.
  • 61
    Huppertz B, Berghold VM, Kawaguchi R, Gauster M: A variety of opportunities for immune interactions during trophoblast development and invasion. Am J Reprod Immunol 2012; 67:349357.
  • 62
    Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, Sharma S: Evidence for interleukin-10-mediated inhibition of cyclo- oxygenase-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol 2006; 55:1927.
  • 63
    Fukui A, Funamizu A, Yokota M, Yamada K, Nakamua R, Fukuhara R, Kimura H, Mizunuma H: Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J Reprod Immunol 2011; 90:105110.
  • 64
    Shynlova O, Nedd-Roderique T, Li Y, Dorogin A, Lye SJ: Myometrial immune cells contribute to term parturition, preterm labour and post-partum involution in mice. J Cell Mol Med 2012; 4:15824934.
  • 65
    Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ: An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994; 171:16601667.
  • 66
    Fried M, Muga RO, Misore AO, Duffy PE: Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol 1998; 160:25232530.
  • 67
    Chan PK, Chang AR, Tam WH, Cheung JL, Cheng AF: Prevalence and genotype distribution of cervical human papillomavirus infection: Comparison between pregnant women and non-pregnant controls. J Med Virol 2002; 67:583588.
  • 68
    Fried M, Duffy PE: Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996; 272:15021504.
  • 69
    Orozco S, Schmid MA, Parameswaran P, Lachica R, Henn MR, Beatty R, Harris E: Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J Gen Virol 2012; 93:21522157.
  • 70
    Powers C, Fruh K: Rhesus CMV: an emerging animal model for human CMV. Med Microbiol Immunol 2008; 197:109115.
  • 71
    Golos TG, Bondarenko GI, Dambaeva SV, Breburda EE, Durning M: On the role of placental major histocompatibility complex and decidual leukocytes in implantation and pregnancy success using non-human primate models. Int J Dev Biol 2010; 54:431443.
  • 72
    Dambaeva SV, Breburda EE, Durning M, Garthwaite MA, Golos TG: Characterization of decidual leukocyte populations in cynomolgus and vervet monkeys. J Reprod Immunol 2009; 80:5769.
  • 73
    Slukvin II, Watkins DI, Golos TG: Phenotypic and functional characterization of rhesus monkey decidual lymphocytes: rhesus decidual large granular lymphocytes express CD56 and have cytolytic activity. J Reprod Immunol 2001; 50:5779.
  • 74
    Dambaeva SV, Durning M, Rozner AE, Golos TG: Immunophenotype and cytokine profiles of rhesus monkey CD56bright and CD56dim decidual natural killer cells. Biol Reprod 2012; 86:110.
  • 75
    Novy MJ, Duffy L, Axthelm MK, Sadowsky DW, Witkin SS, Gravett MG, Cassell GH, Waites KB: Ureaplasma parvum or mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci 2009; 16:5670.
  • 76
    Piotrowski P, Croy BA: Maternal cells are widely distributed in murine fetuses in utero. Biol Reproduction 1996; 54:11031110.
  • 77
    Bonney EA, Matzinger P: The maternal immune system's interaction with circulating fetal cells. J Immunol 1997; 158:4047.
  • 78
    Khosrotehrani K, Johnson KL, Guégan S, Stroh H, Bianchi DW: Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol 2005; 66:112.
  • 79
    Guimond MJ, Wang B, Fujita J, Terhorst C, Croy BA: Pregnancy-associated uterine granulated metrial gland cells in mutant and transgenic mice. Am J Reprod Immunol 1996; 35:501509.
  • 80
    Lin Y, Zhong Y, Shen W, Chen Y, Shi J, Di J, Zeng S, Saito S: TSLP-induced placental DC activation and IL-10(+) NK cell expansion: comparative study based on BALB/c x C57BL/6 and NOD/SCID x C57BL/6 pregnant models. Clin Immunol 2008; 126:104117.
  • 81
    Croy BA: Granulated metrial gland cells: hypotheses concerning possible functions during murine gestation. J Reprod Immunol 1994; 27:8594.
  • 82
    Madeja Z, Yadi H, Apps R, Boulenouar S, Roper SJ, Gardner L, Moffett A, Colucci F, Hemberger M: Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci U S A 2011; 108:40124017.
  • 83
    Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, Claas FH, Walker JJ, Redman CW, Morgan L, Tower C, Regan L, Moore GE, Carrington M, Moffett A: Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010; 120:41024110.
  • 84
    Elliott JM, Yokoyama WM: Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol 2011; 32:364372.
  • 85
    Murphy SP, Hanna NN, Fast LD, Shaw SK, Berg G, Padbury JF, Romero R, Sharma S: Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery. Am J Obstet Gynecol 2009; 200:308309.
  • 86
    Kahn DA, Baltimore D: Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci U S A 2010; 107:92999304.
  • 87
    Rowe JH, Ertelt JM, Xin L, Way SS: Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 2012; 490:102106.
  • 88
    Bonney EA, Shepard MT, Bizargity P: Transient modification within a pool of CD4 T cells in the maternal spleen. Immunology 2011; 134:270280.
  • 89
    Norton MT, Fortner KA, Oppenheimer KH, Bonney EA: Evidence that CD8 T-cell homeostasis and function remain intact during murine pregnancy. Immunology 2010; 131:426437.
  • 90
    Moldenhauer LM, Hayball JD, Robertson SA: Utilising T cell receptor transgenic mice to define mechanisms of maternal T cell tolerance in pregnancy. J Reprod Immunol 2010; 87:113.
  • 91
    Bizargity P, Bonney EA: Dendritic cells: a family portrait at mid-gestation. Immunology 2009; 126:565578.
  • 92
    Erlebacher A, Vencato D, Price KA, Zhang D, Glimcher LH: Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest 2007; 117:13991411.
  • 93
    Padilla-Carlin DJ, McMurray DN, Hickey AJ: The guinea pig as a model of infectious diseases. Comp Med 2008; 58:324340.
  • 94
    Hu X, Wu GP, Zhang MH, Pan SQ, Wang RR, Ouyang JH, Liu JG, Chen ZY, Tian H, Liu DB: GC-MS-based metabolic profiling reveals metabolic changes in anaphylaxis animal models. Anal Bioanal Chem 2012; 404:887893.
  • 95
    Schäfer H, Burger R: Tools for cellular immunology and vaccine research the in the guinea pig: Monoclonal antibodies to cell surface antigens and cell lines. Vaccine 2012; 30:58045811.
  • 96
    Gertz EM, Agarwala R, Mage RG, Schäffer AA: Comparative analysis of genome sequences of the Th2 cytokine region of rabbit (Oryctolagus cuniculus) with those of nine different species. Immunol Immunogenet Insights 2011; 3:5982.
  • 97
    Wattegedera S, Rocchi M, Sales J, Howard CJ, Hope JC, Entrican G: Antigen-specific peripheral immune responses are unaltered during normal pregnancy in sheep. J Reprod Immunol 2008; 77:171178.
  • 98
    Assal-Meliani A, Charpigny G, Reinaud P, Martal J, Chaouat G: Recombinant ovine trophoblastin (roTP) inhibits ovine, murine and human lymphocyte proliferation. J Reprod Immunol 1993; 25:149165.
  • 99
    Mincheva-Nilsson L: Pregnancy and gamma/delta T cells: taking on the hard questions. Reprod Biol Endocrinol 2003; 1:120.
  • 100
    Fan DX, Duan J, Li MQ, Xu B, Li DJ, Jin LP: The decidual gamma-delta T cells up-regulate the biological functions of trophoblasts via IL-10 secretion in early human pregnancy. Clin Immunol 2011; 141:284292.
  • 101
    Exley MA, Boyson JE: Protective role of regulatory decidual gammadelta T cells in pregnancy. Clin Immunol 2011; 141:236239.
  • 102
    Fox A, Maddox JF, de Veer MJ, Meeusen EN: GammadeltaTCR+ cells of the pregnant ovine uterus express variable T cell receptors and contain granulysin. J Reprod Immunol 2010; 84:5256.
  • 103
    Majewski AC, Tekin S, Hansen PJ: Local versus systemic control of numbers of endometrial T cells during pregnancy in sheep. Immunology 2001; 102:317322.
  • 104
    Engelhardt H, Croy BA, King GJ: Role of uterine immune cells in early pregnancy in pigs. J Reprod Fertil Suppl 1997; 52:115131.
  • 105
    Clancy B, Finlay BL, Darlington RB, Anand KJ: Extrapolating brain development from experimental species to humans. NeuroToxicology 2007; 28:931937.
  • 106
    Zhou Q, Renard JP, Le Friec G, Brochard V, Beaujean N, Cherifi Y, Fraichard A, Cozzi J: Generation of fertile cloned rats by regulating oocyte activation. Science 2003; 302:1179.
  • 107
    Dickinson H, Walker DW, Cullen-McEwen L, Wintour EM, Moritz K: The spiny mouse (Acomys cahirinus) completes nephrogenesis before birth. Am J Physiol Renal Physiol 2005; 289:F273F279.
  • 108
    Seifert AW, Kiama SG, Seifert MG, Goheen JR, Palmer TM, Maden M: Skin shedding and tissue regeneration in African spiny mice (Acomys). Nature 2012; 489:561565.
  • 109
    Anthony RV, Scheaffer AN, Wright CD, Regnault TR: Ruminant models of prenatal growth restriction. Reprod Suppl 2003; 61:183194.
  • 110
    Sibai B, Dekker G, Kupferminc M: Pre-eclampsia primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2005; 365:785799.
  • 111
    Jacobs M, Nassar N, Roberts CL, Hadfield R, Morris JM, Ashton AW: Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review. Reprod Biol Endocrinol 2011; 9:77.
  • 112
    Brosens IA, Robertson WB, Dixon HG: The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annual 1972; 1:177191.
  • 113
    Bernstein IM, Meyer MC, Osol G, Ward K: Intolerance to volume expansion: a theorized mechanism for the development of preeclampsia. Obstet Gynecol 1998; 92:306308.
  • 114
    Raynor BD, Bonney EA, Jang KT, Coto W, Garcia MS: Preeclampsia and chlamydia pneumoniae: is there a link? Hypert Preg 2004; 23:129134.
  • 115
    Kim YM, Romero R, Oh SY, Kim CJ, Kilburn BA, Armant DR, Nien JK, Gomez R, Mazor M, Saito S, Abrahams VM, Mor G: Toll-like receptor 4: a potential link between “danger signals”, the innate immune system, and preeclampsia? Am J Obstet Gynecol 2005; 193:921927.
  • 116
    Bonney EA: Preeclampsia: a view through the danger model. J Reprod Immunol 2007; 76:6874.
  • 117
    Redman CW, Sargent IL: Immunology of pre-eclampsia. Am J Reprod Immunol 2010; 63:534543.
  • 118
    Roberts JM, Taylor RN, Goldfien A: Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991; 4:700708.
  • 119
    Ilekis JV, Reddy UM, Roberts JM: Preeclampsia–a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007; 14:508523.
  • 120
    McCarthy FP, Kingdom JC, Kenny LC, Walsh SK: Animal models of preeclampsia; uses and limitations. Placenta 2011; 32:413419.
  • 121
    Stout C, Lemmon WB: Glomerular capillary endothelial swelling in a pregnant chimpanzee. Am J Obstet Gynecol 1969; 105:212215.
  • 122
    Sunderland NS, Thomson SE, Heffernan SJ, Lim S, Thompson J, Ogle R, McKenzie P, Kirwan PJ, Makris A, Hennessy A: Tumor necrosis factor alpha induces a model of preeclampsia in pregnant baboons (Papio hamadryas). Cytokine 2011; 56:192199.
  • 123
    Orange S, Rasko JE, Thompson JF, Vaughan J, Olive E, Pedler M, Horvath JS, Hennessy A: Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine 2005; 29:176185.
  • 124
    Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, Sethi S, Weiss RM, Bates JN: Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 2002; 39:337342.
  • 125
    Dokras A, Hoffmann DS, Eastvold JS, Kienzle MF, Gruman LM, Kirby PA, Weiss RM, Davisson RL: Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia. Biol Reprod 2006; 75:899907.
  • 126
    Sharkey LC, Kirchain S, McCune SA, Simpson GI, Archambault EZ, Boatright NK, Hicks E, Fray J: Progesterone increases blood pressure in spontaneous gestational hypertension in rats. Am J Hypertens 2005; 18:3643.
  • 127
    Furuya M, Ishida J, Inaba S, Kasuya Y, Kimura S, Nemori R, Fukamizu A: Impaired placental neovascularization in mice with pregnancy-associated hypertension. Lab Invest 2008; 88:416429.
  • 128
    Geusens N, Hering L, Verlohren S, Luyten C, Drijkoningen K, Taube M, Vercruysse L, Hanssens M, Dechend R, Pijnenborg R: Changes in endovascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model. Placenta 2010; 31:320326.
  • 129
    Bohlender J, Ganten D, Luft FC: Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J Am Soc Nephrol 2000; 11:20562061
  • 130
    Young J: The aetiology of eclampsia and albuminuria and their relation to accidental haemorrhage: (An Anatomical and Experimental Investigation.). Proc R Soc Med 1914; 7:307348.
  • 131
    Li J, LaMarca B, Reckelhoff JF: A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol 2012; 303:H1H8.
  • 132
    Douglas BH: The rat as a model for preeclampsia. Perspect Nephrol Hypertens 1976; 5:411419.
  • 133
    Ianosi-Irimie M, Vu HV, Whitbred JM, Pridjian CA, Nadig JD, Williams MY, Wrenn DC, Pridjian G, Puschett JB: A rat model of preeclampsia. Clin Exp Hypertens 2005; 27:605617.
  • 134
    Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169:13161320.
  • 135
    Maynard SE, Min J-Y, Merchan J, Lim K-H, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Investig 2003; 111:649658.
  • 136
    Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642649.
  • 137
    Seidl DC, Hughes HC, Bertolet R, Lang CM: True pregnancy toxemia (preeclampsia) in the guinea pig (Cavia porcellus). Lab Anim Sci 1979; 29:472478.
  • 138
    Golden JG, Hughes HC, Lang CM: Experimental toxemia in the pregnant guinea pig (Cavia porcellus). Lab Anim Sci 1980; 30:174179.
  • 139
    Abitbol MM, Gallo GR, Pirani CL, Ober WB: Production of experimental toxemia in the pregnant rabbit. Am J Obstet Gynecol 1976; 124:460470.
  • 140
    Al-Qudah KM: Oxidant and antioxidant profile of hyperketonemic ewes affected by pregnancy toxemia. Vet Clin Pathol 2011; 40:6065.
  • 141
    Yarim GF, Ciftci G: Serum protein pattern in ewe with pregnancy toxemia. Vet Res Commun 2009; 33:431438.
  • 142
    Bukowski R: Stillbirth and fetal growth restriction [Review]. Clin Obstet Gynecol 2010; 53:673680.
  • 143
    Wu G, Bazer FW, Wallace JM, Spencer TE: Board-Invited Review: Intrauterine growth retardation: Implications for the animal sciences. J Anim Sci 2006; 84:23162337.
  • 144
    McDonald TJ, Wu G, Nijland MJ, Jenkins SL, Nathanielsz PW, Jansson T: Effect of 30% nutrient restriction in the first half of gestation on maternal and fetal baboon serum amino acid concentrations. Br J Nutr 2012; 9:17.
  • 145
    Roberts VHJ, Räsänen JP, Novy MJ, Frias A, Louey S, Morgan TK, Thornburg KL, Spindel ER, Grigsby PL: Restriction of placental vasculature in a non-human primate: A unique model to study placental plasticity. Placenta 2012; 33:7376.
  • 146
    Royston JP, Flecknell PA, Wootton R: New evidence that the intra-uterine growth-retarded piglet is a member of a discrete subpopulation. Biol Neonate 1982; 42:100104.
  • 147
    Ruster M, Sommer M, Stein G, Bauer K, Walter B, Wolf G, Bauer R: Renal Angiotensin receptor type 1 and 2 upregulation in intrauterine growth restriction of newborn piglets. Cells Tissues Organs 2006; 182:106114.
  • 148
    Hefler LA, Reyes CA, O'Brien WE, Gregg AR: Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod 2001; 64:666673.
  • 149
    Hefler LA, Tempfer CB, Moreno RM, O'Brien WE, Gregg AR: Endothelial-derived nitric oxide and angiotensinogen: blood pressure and metabolism during mouse pregnancy. Am J Physiol Regul Integr Comp Physiol 2001; 280:R174R182.
  • 150
    Puglianiello A, Germani D, Antignani S, Tomba GS, Cianfarani S: Changes in the expression of hypothalamic lipid sensing genes in rat model of intrauterine growth retardation (IUGR). Pediatr Res 2007; 61:433437.
  • 151
    Turner AJ, Trudinger BJ: A modification of the uterine artery restriction technique in the guinea pig fetus produces asymmetrical ultrasound growth. Placenta 2009; 30:236240.
  • 152
    Eixarch E, Batalle D, Illa M, Munoz-Moreno E, Arbat-Plana A, Amat-Roldan I, Figueras F, Gratacos E: Neonatal neurobehavior and diffusion MRI changes in brain reorganization due to intrauterine growth restriction in a rabbit model. PLoS ONE 2012; 7:e31497.
  • 153
    Lecarpentier E, Morel O, Tarrade A, Dahirel M, Bonneau M, Gayat E, Evain-Brion D, Chavatte-Palmer P, Tsatsaris V: Quantification of utero-placental vascularization in a rabbit model of IUGR with three-dimensional power Doppler angiography. Placenta 2012; 33:769775.
  • 154
    Sebert SP, Dellschaft NS, Chan LLY, Street H, Henry M, Francois C, Sharma V, Fainberg HP, Patel N, Roda J, Keisler D, Budge H, Symonds ME: Maternal nutrient restriction during late gestation and early postnatal growth in sheep differentially reset the control of energy metabolism in the gastric mucosa. Endocrinology 2011; 152:28162826.
  • 155
    Laurent A, Pelage J-P, Wassef M, Martal J: Fertility after bilateral uterine artery embolization in a sheep model. Fertil Steril 2008; 89:13711383.
  • 156
    Robinson JS, Kingston EJ, Jones CT, Thorburn GD: Studies on experimental growth retardation in sheep. The effect of removal of a endometrial caruncles on fetal size and metabolism. J Dev Physiol 1979; 1:379398.
  • 157
    Arroyo JA, Anthony RV, Parker TA, Galan HL: Differential expression of placental and vascular endothelial nitric oxide synthase in an ovine model of fetal growth restriction. Am J Obstet Gynecol 2006; 195:771777.
  • 158
    Vuguin PM: Animal models for small for gestational age and fetal programming of adult disease. Horm Res 2007; 68:113123.
  • 159
    Ziebell BT, Galan HL, Anthony RV, Regnault TRH, Parker TA, Arroyo JA: Ontogeny of endothelial nitric oxide synthase mRNA in an ovine model of fetal and placental growth restriction. Am J Obstet Gynecol 2007;197:420.e421420.e425.
  • 160
    Galan HL, Regnault TR, Le Cras TD, Tyson RW, Anthony RV, Wilkening RB, Abman SH: Cotyledon and binucleate cell nitric oxide synthase expression in an ovine model of fetal growth restriction. J Appl Physiol 2001; 90:24202426.
  • 161
    Robinson JS, Jones CT, Kingston EJ: Studies on experimental growth retardation in sheep. The effects of maternal hypoxaemia. J Dev Physiol 1983; 5:89100.
  • 162
    Cummings AM, Kavlock RJ: Gene-environment interactions: a review of effects on reproduction and development. Crit Rev Toxicol 2004; 34:461485.
  • 163
    Craig M: Stress and recurrent miscarriage. Stress 2001; 4:205213.
  • 164
    Mathias S, Allen WR: Immunization with stallion lymphocytes for treatment of recurrent spontaneous abortion in thoroughbred mares. J Reprod Fertil Suppl 2000; 56:645650.
  • 165
    Croy BA, Wessels JM, Linton NF, van den Heuvel M, Edwards AK, Tayade C: Cellular and molecular events in early and mid gestation porcine implantation sites: a review. Soc Reprod Fertil Suppl 2009; 66:233244.
  • 166
    Nakashima A, Shima T, Inada K, Ito M, Saito S: The balance of the immune system between T cells and NK cells in miscarriage. Am J Reprod Immunol 2012; 67:304310.
  • 167
    Nielsen HS: Secondary recurrent miscarriage and H-Y immunity. Hum Reprod Update 2011; 17:558574.
  • 168
    Bansal AS, Bajardeen B, Thum MY: The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J Reprod Immunol 2012; 93:4151.
  • 169
    Knapp LA, Ha JC, Sackett GP: Parental MHC antigen sharing and pregnancy wastage in captive pigtailed macaques. J Reprod Immunol 1996; 32:7388.
  • 170
    Owiti GE, Tarantal AF, Lasley BL, Hendrickx AG: The effect of the anti-progestin RU 486 on early pregnancy in the long-tailed macaque (Macaca fascicularis). Contraception 1989; 40:201211.
  • 171
    Smith MA, Takeuchi K, Brackett RE, McClure HM, Raybourne RB, Williams KM, Babu US, Ware GO, Broderson JR, Doyle MP: Nonhuman primate model for Listeria monocytogenes-induced stillbirths. Infect Immun 2003; 71:15741579.
  • 172
    Ho HN, Chen SU, Yang YS, Huang SC, Lee TY, Gill TJ 3rd: Age, environment, and lymphocyte immunization influence the spontaneous resorption rate in the CBA/J x DBA/2J mouse model. Am J Reprod Immunol 1994; 31:4751.
  • 173
    Haddad EK, Duclos AJ, Baines MG: Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med 1995; 182:11431152.
  • 174
    Clark DA, Chaput A, Tutton D: Active suppression of host-vs-graft reaction in pregnant mice. VII. Spontaneous abortion of allogeneic CBA/J x DBA/2 fetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity. J Immunol 1986; 136:16681675.
  • 175
    Arck PC, Merali FS, Manuel J, Chaouat G, Clark DA: Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factor-alpha (TNF-alpha) release as a mechanism triggering resorptions in mice. Am J Reprod Immunol 1995; 33:7480.
  • 176
    Toder V, Strassburger D, Carp H, Irlin I: Mouse model for the treatment of immune pregnancy loss. Am J Reprod Immunol 1991; 26:4246.
  • 177
    Clark DA, Manuel J, Lee L, Chaouat G, Gorczynski RM, Levy GA: Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA x DBA/2 mouse model. I. Synergistic effect of LPS and (TNF-alpha + IFN-gamma) on pregnancy loss. Am J Reprod Immunol 2004; 52:370378.
  • 178
    Chaouat G, Menu E, Delage G, Moreau JF, Khrishnan L, Hui L, Meliani AA, Martal J, Raghupathy R, Lelaidier C, Bertrand C, Freitas S, Hambartsumian E, Wegmann TG, Frydman R: Immuno-endocrine interactions in early pregnancy. Hum Reprod 1995; 10(Suppl. 2):5559.
  • 179
    Chaouat G, Meliani AA, Martal J, Raghupathy R, Eliot J, Mosmann T, Wegmann TG: IL-10 prevents naturally occuring fetal loss in the CBAxDBA/2 mating combination, and local defect in IL-10 production in the abortion-prone combination is corrected by in vivo injection of IFN-τ. J Immunol 1995; 154:42614268.
  • 180
    Zenclussen AC, Gerlof K, Zenclussen ML, Ritschel S, Zambon Bertoja A, Fest S, Hontsu S, Ueha S, Matsushima K, Leber J, Volk H-D: Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface.[see comment]. Eur J Immunol 2006; 36:8294.
  • 181
    Wafula PO, Teles A, Schumacher A, Pohl K, Yagita H, Volk HD, Zenclussen AC: PD-1 but not CTLA-4 blockage abrogates the protective effect of regulatory T cells in a pregnancy murine model. Am J Reprod Immunol 2009; 62:283292.
  • 182
    Dixon ME, Chien EK, Osol G, Callas PW, Bonney EA: Failure of decidual arteriolar remodeling in the CBA/J x DBA/2 murine model of recurrent pregnancy loss is linked to increased expression of tissue inhibitor of metalloproteinase 2 (TIMP-2). Am J Obstet Gynecol 2006; 194:113119.
  • 183
    Redecha P, van Rooijen N, Torry D, Girardi G: Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 2009; 113:41014109.
  • 184
    Chaouat G, Kiger N, Wegmann TG: Vaccination against spontaneous abortion in mice. J Reprod Immunol 1983; 5:389392.
  • 185
    Jin LP, Zhou YH, Zhu XY, Wang MY, Li DJ: Adoptive transfer of paternal antigen-hyporesponsive T cells facilitates a Th2 bias in peripheral lymphocytes and at materno-fetal interface in murine abortion-prone matings. Am J Reprod Immunol 2006; 56:258266.
  • 186
    Bertoja AZ, Zenclussen ML, Casalis PA, Sollwedel A, Schumacher A, Woiciechowsky C, Volk HD, Zenclussen AC: Anti-P- and E-selectin therapy prevents abortion in the CBA/J x DBA/2J combination by blocking the migration of Th1 lymphocytes into the foetal-maternal interface. Cell Immunol 2005; 238:97102.
  • 187
    Zhao F-X, Zhang Y-Y, Liu R-H, Li S-M: Effect of blockage of costimulatory signal on murine abortion-prone model. Chin Med J 2007; 120:12471250.
  • 188
    Samstein Robert M, Josefowicz Steven Z, Arvey A, Treuting Piper M, Rudensky Alexander Y: Extrathymic generation of regulatory T Cells in placental mammals mitigates maternal-fetal conflict. Cell 2012;150:2938.
  • 189
    Boyson JE, Nagarkatti N, Nizam L, Exley MA, Strominger JL: Gestation stage-dependent mechanisms of invariant natural killer T cell-mediated pregnancy loss. Proc Natl Acad Sci U S A 2006; 103:45804585.
  • 190
    Tayade C, Fang Y, Croy BA: A review of gene expression in porcine endometrial lymphocytes, endothelium and trophoblast during pregnancy success and failure. J Reprod Dev 2007; 53:455463.
  • 191
    Harrison CJ, Caruso N: Correlation of maternal and pup NK-like activity and TNF responses against cytomegalovirus to pregnancy outcome in inbred guinea pigs. J Med Virol 2000; 60:230236.
  • 192
    Rodolakis A, Salinas J, Papp J: Recent advances on ovine chlamydial abortion. Vet Res 1998; 29:275288.
  • 193
    Pierangeli SS, Harris EN: Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone. Clin Exp Immunol 1993; 93:269272.
  • 194
    Elovitz MA: Animal models of pre-term birth. Havemeyer Found Monog Series 2004; 15:479487.
  • 195
    Kamath-Rayne BD, Defranco EA, Chung E, Chen A: Subtypes of preterm birth and the risk of postneonatal death. J Pediatr 2012; 7:7.
  • 196
    Mercer BM, Macpherson CA, Goldenberg RL, Goepfert AR, Hauguel-de Mouzon S, Varner MW, Iams JD, Meis PJ, Moawad AH, Miodovnik M, Caritis SN, Van Dorsten JP, Sorokin Y, Thurnau GR, Spong CY: Are women with recurrent spontaneous preterm births different from those without such history? Am J Obstet Gynecol 2006; 194:11761184.
  • 197
    Schuit E, Stock S, Groenwold RH, Maurel K, Combs CA, Garite T, Spong CY, Thom EA, Rouse DJ, Caritis SN, Saade GR, Zachary JM, Norman JE, Rode L, Klein K, Tabor A, Cetingoz E, Morrison JC, Magann EF, Briery CM, Serra V, Perales A, Meseguer J, Nassar AH, Lim AC, Moons KG, Kwee A, Mol BW: Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials. BMC Pregnancy Childbirth 2012; 12:13.
  • 198
    Gervasi MT, Romero R, Bracalente G, Erez O, Dong Z, Hassan SS, Yeo L, Yoon BH, Chaiworapongsa T: Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med 2012; 40:329343.
  • 199
    Romero R, Chaiworapongsa T, Alpay Savasan Z, Xu Y, Hussein Y, Dong Z, Kusanovic JP, Kim CJ, Hassan SS: Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med 2011; 24:14441455.
  • 200
    Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH: Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357:462469.
  • 201
    Sanchez SE, Alva AV, Diez Chang G, Qiu C, Yanez D, Gelaye B, Williams MA: Risk of spontaneous preterm birth in relation to maternal exposure to intimate partner violence during pregnancy in Peru. Matern Child Health J 2012; 17:17.
  • 202
    Aliaga S, Price W, McCaffrey M, Ivester T, Boggess K, Tolleson-Rinehart S: Practice variation in late-preterm deliveries: a physician survey. J Perinatol 2012; 27:119.
  • 203
    Murray SA, Morgan JL, Kane C, Sharma Y, Heffner CS, Lake J, Donahue LR: Mouse gestation length is genetically determined. PLoS ONE 2010; 5:e12418.
  • 204
    Robertson SA, Christiaens I, Dorian CL, Zaragoza DB, Care AS, Banks AM, Olson DM: Interleukin-6 is an essential determinant of on-time parturition in the mouse. Endocrinology 2010; 151:39964006.
  • 205
    Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S: Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348:23792385.
  • 206
    Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GWfor the PT: Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38:1831.
  • 207
    Bastek J, Adamczak J, Hoffman S, Elovitz M, Srinivas S: Trends in prematurity: What do changes at an urban institution suggest about the public health impact of 17-alpha hydroxyprogesterone caproate? Matern Child Health J 2012; 16:564568.
  • 208
    Manuck TA, Lai Y, Meis PJ, Dombrowski MP, Sibai B, Spong CY, Rouse DJ, Durnwald CP, Caritis SN, Wapner RJ, Mercer BM, Ramin SM: Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 2011;205:135 e131135 e139.
  • 209
    Gorenberg D, Beharry K, Nishihara KC, Chang E, Waltzman J, Akmal A, Asrat T: Dose response of RU486 in a novel rabbit model of noninfectious preterm birth: comparative efficacy of 3 routes of administration. Am J Obstet Gynecol 2005; 192:924931.
  • 210
    Hirota Y, Cha J, Yoshie M, Daikoku T, Dey SK: Heightened uterine mammalian target of rapamycin complex 1 (mTORC1) signaling provokes preterm birth in mice. Proc Natl Acad Sci U S A 2011; 108:1807318078.
  • 211
    Mendelson CR, Condon JC: New insights into the molecular endocrinology of parturition. J Steroid Biochem Mol Biol 2005; 93:113119.
  • 212
    Condon JC, Jeyasuria P, Faust JM, Mendelson CR: Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci U S A 2004; 101:49784983.
  • 213
    Adams WM, Wagner WC: The role of corticoids in parturition. Biology Report 1970; 3:228.
  • 214
    Challis JR, Manchester EL, Mitchell BF, Patrick JE: Activation of adrenal function in fetal sheep by the infusion of adrenocorticotropin to the fetus in utero. Biol Reprod 1982; 27:10261032.
  • 215
    Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M: A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003; 163:21032111.
  • 216
    Hirsch E, Saotome I, Hirsh D: A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 1995; 172:15981603.
  • 217
    Bizargity P, Del Rio R, Phillippe M, Teuscher C, Bonney EA: Resistance to lipopolysaccharide-induced preterm delivery mediated by regulatory T cell function in mice. Biol Reprod 2009; 80:874881.
  • 218
    Dombroski RA, Woodard DS, Harper MJK, Gibbs RS: A rabbit model for bacteria-induced preterm pregnancy loss. Am J Obstet Gynecol 1990; 163:19381943.
  • 219
    Katsuki Y, Kaga N, Kakinuma C, Takagaki K, Kajikawa S, Shibutani Y: Ability of intrauterine bacterial lipopolysaccharide to cause in situ uterine contractions in pregnant rabbits. Acta Obstet Gynecol Scand 1997; 76:2632.
  • 220
    Davies JK, Shikes RH, Sze CI, Leslie KK, McDuffie RS Jr, Romero R, Gibbs RS: Histologic inflammation in the maternal and fetal compartments in a rabbit model of acute intra-amniotic infection. Am J Obstet Gynecol 2000; 183:10881093.
  • 221
    Gravett MG: Animal models for infection-induced preterm birth. Infection-induced preterm birth in non-human primates. Abst Intersci Conf Antimicrob Agents Chemot 2006; 46:497.
  • 222
    Adams Waldorf KM, Persing D, Novy MJ, Sadowsky DW, Gravett MG: Pretreatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci 2008; 15: 121127.
  • 223
    Gravett MG, Adams KM, Sadowsky DW, Grosvenor AR, Witkin SS, Axthelm MK, Novy MJ: Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model. Am J Obstet Gynecol 2007; 197:518.e511518.e518.
  • 224
    Yellon SM, Ebner CA, Elovitz MA: Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth. Reprod Sci 2009; 16:257264.
  • 225
    Bytautiene E, Romero R, Vedernikov YP, El-Zeky F, Saade GR, Garfield RE: Induction of premature labor and delivery by allergic reaction and prevention by histamine H1 receptor antagonist. Am J Obstet Gynecol 2004; 191:13561361.
  • 226
    Bytautiene E, Vedernikov YP, Saade GR, Romero R, Garfield RE: IgE-independent mast cell activation augments contractility of nonpregnant and pregnant guinea pig myometrium. Int Arch Allergy Immunol 2008; 147:140146.
  • 227
    Kass EH: Effect of corticosteroids and of hormones of pregnancy on the lethal action of bacterial endotoxin bacteriuria and pyelonephritis of pregnancy. Ann N Y Acad Sci 1960; 88:107115.
  • 228
    Henderson M, Entwisle G, Tayback M: Bacteriuria and pregnancy outcome: preliminary findings. Am J Public Health Nations Health 1962; 52:18871893.
  • 229
    Harper MJ, Skarnes RC: Inhibition of abortion and fetal death produced by endotoxin or prostaglandin F2alpha. Prostaglandins 1972; 2:295309.
  • 230
    Wren BG: Premature labour with renal infections: the action of coliform endotoxin on the pregnant rat uterus. Aust N Z J Obstet Gynaecol 1970; 10:211217.
  • 231
    Anderson KV, Jurgens G, Nusslein-Volhard C: Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 1985; 42:779789.
  • 232
    Romero R, Mazor M, Tartakovsky B: Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991; 165:t-71.
  • 233
    Fidel PL Jr, Romero R, Wolf N, Cutright J, Ramirez M, Araneda H, Cotton DB: Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994; 170:14671475.
  • 234
    Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394397.
  • 235
    Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274:1740617409.
  • 236
    Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395:284288.
  • 237
    Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189:615625.
  • 238
    Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA: Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 2002; 52:373376.
  • 239
    Filipovich Y, Lu SJ, Akira S, Hirsch E: The adaptor protein MyD88 is essential for E. coli-induced preterm delivery in mice. Am J Obstet Gynecol 2009; 200:93 e9193 e98.
  • 240
    Blank V, Hirsch E, Challis JRG, Romero R, Lye SJ: Cytokine signaling, inflammation, innate immunity and preterm labour - a workshop report. Placenta 2008;29(Suppl. A):S102S104.
  • 241
    Lin Y, Xie M, Chen Y, Di J, Zeng Y: Preterm delivery induced by LPS in syngeneically impregnated BALB/c and NOD/SCID mice. J Reprod Immunol 2006; 71:87101.
  • 242
    Wang H, Hirsch E: Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol Reprod 2003; 69:19571963.
  • 243
    Beijar EC, Mallard C, Powell TL: Expression and subcellular localization of TLR-4 in term and first trimester human placenta. Placenta 2006; 27:322326.
  • 244
    Kim YM, Romero R, Chaiworapongsa T, Kim GJ, Kim MR, Kuivaniemi H, Tromp G, Espinoza J, Bujold E, Abrahams VM, Mor G: Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004; 191:13461355.
  • 245
    Hirschfeld AF, Jiang R, Robinson WP, McFadden DE, Turvey SE: Toll-like receptor 4 polymorphisms and idiopathic chromosomally normal miscarriage. Hum Reprod 2007; 22:440443.
  • 246
    Ilievski V, Hirsch E: Synergy between viral and bacterial toll-like receptors leads to amplification of inflammatory responses and preterm labor in the mouse. Biol Reprod 2010; 83:767773.
  • 247
    Koga K, Cardenas I, Aldo P, Abrahams VM, Peng B, Fill S, Romero R, Mor G: Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol 2009; 61:196212.
  • 248
    Abrahams VM, Aldo PB, Murphy SP, Visintin I, Koga K, Wilson G, Romero R, Sharma S, Mor G: TLR6 modulates first trimester trophoblast responses to peptidoglycan. J Immunol 2008; 180:60356043.
  • 249
    Cardenas I, Mor G, Aldo P, Lang SM, Stabach P, Sharp A, Romero R, Mazaki-Tovi S, Gervasi M, Means RE: Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am J Reprod Immunol 2011; 65:110117.
  • 250
    Scharfe-Nugent A, Corr SC, Carpenter SB, Keogh L, Doyle B, Martin C, Fitzgerald KA, Daly S, O'Leary JJ, O'Neill LAJ: TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. J Immunol 2012; 188:57065712.
  • 251
    Inder T, Neil J, Yoder B, Rees S: Patterns of cerebral injury in a primate model of preterm birth and neonatal intensive care. J Child Neurol 2005; 20:965967.
  • 252
    Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G: Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth.[comment]. Am J Obstet Gynecol 2004; 190:15091519.
  • 253
    Kim YM, Romero R, Chaiworapongsa T, Espinoza J, Mor G, Kim CJ: Dermatitis as a component of the fetal inflammatory response syndrome is associated with activation of Toll-like receptors in epidermal keratinocytes. Histopathology 2006; 49:506514.
  • 254
    Bell MJ, Hallenbeck JM, Gallo V: Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res 2004; 56:541546.
  • 255
    Rees SM, Duncan J, Loeliger M, Cock M, Harding R: Repeated exposure to bacterial endotoxin during gestation leads to cerebral white matter and retinal damage in the ovine fetus. Soc Neurosci Abs 2001; 27:2406.
  • 256
    Saadani-Makki F, Kannan S, Lu X, Janisse J, Dawe E, Edwin S, Romero R, Chugani D: Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol 2008; 199:651.e651651.e657.
  • 257
    Burd I, Chai J, Gonzalez J, Ofori E, Monnerie H, Le Roux PD, Elovitz MA: Beyond white matter damage: fetal neuronal injury in a mouse model of preterm birth. Am J Obstet Gynecol 2009; 201:279.e18.
  • 258
    Breen K, Brown A, Burd I, Chai J, Friedman A, Elovitz MA: TLR-4-dependent and -independent mechanisms of fetal brain injury in the setting of preterm birth. Reprod Sci 2012; 19:839850.
  • 259
    Elovitz MA, Mrinalini C, Sammel MD: Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr Res 2006; 59:5055.
  • 260
    Robertson SA, Skinner RJ, Care AS: Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006; 177:48884896.
  • 261
    Thaxton JE, Romero R, Sharma S: TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 2009; 183:11441154.
  • 262
    Dordelmann M, Kerk J, Dressler F, Brinkhaus MJ, Bartels DB, Dammann CEL, Dork T, Dammann O: Interleukin-10 high producer allele and ultrasound-defined periventricular white matter abnormalities in preterm infants: a preliminary study. Neuropediatrics 2006; 37:130136.
  • 263
    Barker DJP: In utero programming of cardiovascular disease. Theriogenology 2000; 53:555574.
  • 264
    Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS: Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341:938941.
  • 265
    Seki Y, Williams L, Vuguin PM, Charron MJ: Minireview: Epigenetic programming of diabetes and obesity: animal models. Endocrinology 2012; 153:10311038.
  • 266
    Long NM, Ford SP, Nathanielsz PW: Multigenerational effects of fetal dexamethasone exposure on the hypothalamic-pituitary-adrenal axis of first and second generation female offspring. Am J Obstet Gynecol 2012; 6:014.
  • 267
    Okada Y, Ueshin Y, Isotani A, Saito-Fujita T, Nakashima H, Kimura K, Mizoguchi A, Oh-hora M, Mori Y, Ogata M, Oshima RG, Okabe M, Ikawa M: Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer. Nat Biotech 2007; 25:233237.
  • 268
    Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, Irie J, Sirota M, Morgan AA, Chen R, Ohtsu H, Maeda S, Kadowaki T, Butte AJ: Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A 2012; 109:70497054.
  • 269
    Hou ZC, Sterner KN, Romero R, Than NG, Gonzalez JM, Weckle A, Xing J, Benirschke K, Goodman M, Wildman DE: Elephant transcriptome provides insights into the evolution of eutherian placentation. Genome Biol Evol 2012; 4:713725.
  • 270
    Shorten PR, Peterson AJ, O'Connell AR, Juengel JL, McNatty KP, Soboleva TK: A mathematical model of pregnancy recognition in mammals. J Theor Biol 2010; 266:6269.
  • 271
    Williams PH, Eyles R, Weiller G: Plant MicroRNA prediction by supervised machine learning using C5.0 Decision Trees. J Nucleic Acids 2012; 2012:652979.